Cresco Labs Inc. (CRLBF) Payables (2019 - 2026)

Cresco Labs (CRLBF) has reported Payables for 8 consecutive years, with $16.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables fell 44.53% year-over-year to $16.3 million; the trailing twelve-month figure through Jun 2026 stood at $16.3 million (down 44.53% YoY), and the FY2025 full-year result was $27.3 million, up 6.8% from the prior year.
• Payables climbed to $16.3 million in Q2 2026 per CRLBF's latest filing, from $14.2 million in the prior quarter.
• Across five years, Payables topped out at $62.5 million in Q1 2022 and bottomed at $14.2 million in Q1 2026.
• Historically, Payables has averaged $36.5 million across 5 years, with a median of $34.9 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Payables soared 41.35% in 2022, then tumbled 63.72% in 2026.
• Over 5 years, Payables stood at $28.1 million in 2022, then decreased by 1.8% to $27.6 million in 2023, then dropped by 7.26% to $25.6 million in 2024, then grew by 6.8% to $27.3 million in 2025, then slumped by 40.31% to $16.3 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $16.3 million, $14.2 million, and $27.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.